Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
China Pharmacy ; (12): 299-300, 2001.
Artículo en Chino | WPRIM | ID: wpr-410511

RESUMEN

OBJECTIVE: To develop a method of thin- layer chromatographic scanning to determine the content of puerarin in Jiangtang pill METHODS: Silica GF254 thin- layer was used, and the mobile phase consisted of chloroform- methanol- water(7∶ 2 5∶ 0 25) with the detection wave- length of 254nm and the control wave- length of 370nm RESULTS: The linear range of puerarin was 0 4~ 2 0μ g The mean recovery was 99 40% (n=5) with RSD of 1 37%  CONCLUSION: This method is accurate, reliable and can be used for the determination of puerarin in Jiangtang pill

2.
Chinese Traditional and Herbal Drugs ; (24)1994.
Artículo en Chino | WPRIM | ID: wpr-576875

RESUMEN

Objective To investigate the intestinal absorption kinetics of breviscapine in rats.MethodsThe intestinal absorption in small intestine and colon of rats in situ was investigated using circular perfusion and HPLC methods.The in situ absorption of scutellarin in the small intestine was studied and the effects on the intestinal absorption were observed at the various concentrations and different pH values using the same methods.Results The results showed that there were significant differences in both absorptive percentage and absorption rate constant(ka)in the small intestine between the experimental groups of rats with and without bile duct being ligated.The absorption rate constants in small intestine and colon were(0.107 1?0.013 0)and(0.070 7?0.008 9)h-1,respectively.No saturation phenomenon occurred and ka was almost kept unchanged at different concentrations of breviscapine.The absorption of breviscapine was not influenced by pH values ranging from 6.0 to 7.4.Conclusion The results indicates that breviscapine is absorbed more in small intestine than in colon.The absorption of breviscapine complied with the passive diffusion mechanism and first order kinetics.In conclusion,these results suggest that breviscapine could be prepared in oral sustained-release dosage form.

3.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-681105

RESUMEN

Objective: To study the feasibility of percutaneous absorption of Compound Patch of Hyperosteogeny(CPH). Methods: The content of ferulic acid,an index composition in percutaneous receptor fluid and release receptor fluid were determined by HPLC.Results: The results of in vitro transdermal delivery experiment and in vitro release experiment showed that ferulic acid permeated at the constant speed of 0.2142?g?cm -2 ?h -1 in 24 hours and its release coincided with Higuchi Equation.Futhermore,the release rate was 14.53?g?cm -2 ?h -1/2 . Conclusion: CPH is a skeleton controlledtransdermal delivery system whose permeation speed is limited by skin.

4.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-577544

RESUMEN

0.05).But the P_ eff values were significantly increased in the presence of P-glycoportein(P-gp)inhibitor,verapamil or digoxin.CONCLUSION:Rhamnosylvitexin can be classified into high penetrating drug.Passive diffusion dominates the absorptive transport behavior of rhamnosylvitexin in HLF.There is not a preferential absorption zone in the intestine for rhamnosylvitexin.The absorption and secretion of rhamnosylvitexin in HLF are mediated by the efflux transport system,P-gp.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA